2023-506508-18-00RecruitingPhase 2/3
Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Jun 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 113 (estimated)
- First submitted
- 5 Oct 2023
- Start date
- 19 Jan 2024
- Lead sponsor
- UZ Leuven
- Diseases
- Lewy body dementia
- EU CT number
- 2023-506508-18-00
What you commit to
- Study type: Interventional · Phase 2/3
- Planned participants: 113
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Gent | Gent | Belgium | Recruiting |
| UZ Leuven | Leuven | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.